Delivery Order SPE2DR25D1205-SPE2DR26F0VX4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $69,230.76 on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 17, 2025, and represents a routine pharmaceutical procurement within the federal medical supply system. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,130.90. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VX4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, for the supply of Janumet 50-1,000 mg tablets (1,000 count) with a ceiling value of $60,770.17. The award, announced on October 29, 2025, with an ultimate completion date of October 30, 2025, was made on a firm fixed-price basis without a set-aside designation, indicating open and competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive federal contracting history demonstrates its capability to fulfill complex pharmaceutical procurement requirements for defense and civilian healthcare programs, supporting entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.8k | 10/29/25 |